Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-188869

Chief Business Officer sold 2,326 shares at $71.27 ($165,774)

  • Chief Business Officer gave up 2,674 shares (to pay taxes)
  • Chief Business Officer acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Robb Gary Charles · Chief Business Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-22 Exercise or conversion : show line 1 in the form +5,000 $3.88 $19,400 18,364 D
2025-08-22 Sale : show line 2 in the form −2,326 $71.27 $165,774 16,038 D
2025-08-22 Shares withheld for taxes : show line 3 in the form −2,674 $71.17 $190,309 13,364 D
Open-market sales · 2,326 sh · avg $71.27 · $165,774

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-22 Exercise or conversion : show line 4 in the form Stock option (right to buy) −5,000 145,000 D
Loading xslF345X05/ownership.xml…